TY - JOUR AU - Hammond, M. E. AU - Hayes, D. F. AU - Dowsett, M. PY - 2010 DA - 2010// TI - American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.6529 DO - 10.1200/JCO.2009.25.6529 ID - Hammond2010 ER - TY - JOUR AU - Wolff, A. C. AU - Hammond, M. E. AU - Hicks, D. G. PY - 2014 DA - 2014// TI - Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update JO - Arch Pathol Lab Med VL - 138 UR - https://doi.org/10.5858/arpa.2013-0953-SA DO - 10.5858/arpa.2013-0953-SA ID - Wolff2014 ER - TY - JOUR AU - Rakha, E. A. AU - Ellis, I. O. PY - 2009 DA - 2009// TI - Triple-negative/basal-like breast cancer: review JO - Pathology VL - 41 UR - https://doi.org/10.1080/00313020802563510 DO - 10.1080/00313020802563510 ID - Rakha2009 ER - TY - JOUR AU - Rakha, E. A. AU - El-Sayed, M. E. AU - Green, A. R. PY - 2007 DA - 2007// TI - Prognostic markers in triple-negative breast cancer JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22381 DO - 10.1002/cncr.22381 ID - Rakha2007 ER - TY - JOUR AU - Dent, R. AU - Trudeau, M. AU - Pritchard, K. I. PY - 2007 DA - 2007// TI - Triple-negative breast cancer: clinical features and patterns of recurrence JO - Clin Cancer Res VL - 13 UR - https://doi.org/10.1158/1078-0432.CCR-06-3045 DO - 10.1158/1078-0432.CCR-06-3045 ID - Dent2007 ER - TY - JOUR AU - Wang, Y. AU - Cao, S. AU - Chen, Y. PY - 2015 DA - 2015// TI - Molecular treatment of different breast cancers JO - Anticancer Agents Med Chem VL - 15 UR - https://doi.org/10.2174/1871520615666150129211901 DO - 10.2174/1871520615666150129211901 ID - Wang2015 ER - TY - JOUR AU - Tomao, F. AU - Papa, A. AU - Zaccarelli, E. PY - 2015 DA - 2015// TI - Triple-negative breast cancer: new perspectives for targeted therapies JO - Onco Targets Ther VL - 8 UR - https://doi.org/10.2147/OTT.S67673 DO - 10.2147/OTT.S67673 ID - Tomao2015 ER - TY - JOUR AU - Reijm, E. A. AU - Timmermans, A. M. AU - Look, M. P. PY - 2014 DA - 2014// TI - High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu391 DO - 10.1093/annonc/mdu391 ID - Reijm2014 ER - TY - JOUR AU - Bachmann, I. M. AU - Halvorsen, O. J. AU - Collett, K. PY - 2006 DA - 2006// TI - EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.01.5180 DO - 10.1200/JCO.2005.01.5180 ID - Bachmann2006 ER - TY - JOUR AU - Karsli-Ceppioglu, S. AU - Dagdemir, A. AU - Judes, G. PY - 2014 DA - 2014// TI - Epigenetic mechanisms of breast cancer: an update of the current knowledge JO - Epigenomics VL - 6 UR - https://doi.org/10.2217/epi.14.59 DO - 10.2217/epi.14.59 ID - Karsli-Ceppioglu2014 ER - TY - JOUR AU - Gonzalez, M. E. AU - Moore, H. M. AU - Li, X. PY - 2014 DA - 2014// TI - EZH2 expands breast stem cells through activation of NOTCH1 signaling JO - Proc Natl Acad Sci USA VL - 111 UR - https://doi.org/10.1073/pnas.1308953111 DO - 10.1073/pnas.1308953111 ID - Gonzalez2014 ER - TY - JOUR AU - Li, T. AU - Cai, J. AU - Ding, H. PY - 2014 DA - 2014// TI - EZH2participates in malignant biological behavior of epithelial ovarian cancer through regulating the expression of BRCA1 JO - Cancer Biol Ther VL - 15 UR - https://doi.org/10.4161/cbt.27306 DO - 10.4161/cbt.27306 ID - Li2014 ER - TY - JOUR AU - Jene-Sanz, A. AU - Váraljai, R. AU - Vilkova, A. V. PY - 2013 DA - 2013// TI - Expression of polycomb targets predicts breast cancerprognosis JO - Mol Cell Biol VL - 33 UR - https://doi.org/10.1128/MCB.00426-13 DO - 10.1128/MCB.00426-13 ID - Jene-Sanz2013 ER - TY - JOUR AU - Granit, R. Z. AU - Gabai, Y. AU - Hadar, T. PY - 2013 DA - 2013// TI - EZH2 promotes a bi-lineage identity in basal-like breast cancercells JO - Oncogene VL - 32 UR - https://doi.org/10.1038/onc.2012.390 DO - 10.1038/onc.2012.390 ID - Granit2013 ER - TY - JOUR AU - Holm, K. AU - Grabau, D. AU - Lövgren, K. PY - 2012 DA - 2012// TI - Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes JO - Mol Oncol VL - 6 UR - https://doi.org/10.1016/j.molonc.2012.06.002 DO - 10.1016/j.molonc.2012.06.002 ID - Holm2012 ER - TY - JOUR AU - Brot, M. AU - Rocha, R. M. AU - Soares, F. A. PY - 2012 DA - 2012// TI - Prognostic impact of the cancer stem cell related markers ALDH1 and EZH2 in triple negative and basal-like breast cancers JO - Pathology VL - 44 UR - https://doi.org/10.1097/PAT.0b013e3283534bcb DO - 10.1097/PAT.0b013e3283534bcb ID - Brot2012 ER - TY - JOUR AU - Ren, G. AU - Baritaki, S. AU - Marathe, H. PY - 2012 DA - 2012// TI - Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP inbreast and prostate cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3546 DO - 10.1158/0008-5472.CAN-11-3546 ID - Ren2012 ER - TY - JOUR AU - Hussein, Y. R. AU - Sood, A. K. AU - Bandyopadhyay, S. PY - 2012 DA - 2012// TI - Clinical and biological relevance of enhancer of zeste homolog 2 in triple-negative breast cancer JO - Hum Pathol VL - 43 UR - https://doi.org/10.1016/j.humpath.2011.12.004 DO - 10.1016/j.humpath.2011.12.004 ID - Hussein2012 ER - TY - JOUR AU - Kalashnikova, E. V. AU - Revenko, A. S. AU - Gemo, A. T. PY - 2010 DA - 2010// TI - ANCCA/ATAD2 overexpression identifies breast cancer patients with poor prognosis, acting to drive proliferation and survival of triple-negative cells through control of B-Myb and EZH2 JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-1199 DO - 10.1158/0008-5472.CAN-10-1199 ID - Kalashnikova2010 ER - TY - JOUR AU - Fujii, S. AU - Tokita, K. AU - Wada, N. PY - 2011 DA - 2011// TI - MEK-ERK pathway regulates EZH2 overexpression in association with aggressive breast cancer subtypes JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2011.118 DO - 10.1038/onc.2011.118 ID - Fujii2011 ER - TY - JOUR AU - Collett, K. AU - Eide, G. E. AU - Arnes, J. PY - 2006 DA - 2006// TI - Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-1533 DO - 10.1158/1078-0432.CCR-05-1533 ID - Collett2006 ER - TY - JOUR AU - Kleer, C. G. AU - Cao, Q. AU - Varambally, S. PY - 2003 DA - 2003// TI - EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells JO - Proc Natl Acad Sci U S A VL - 100 UR - https://doi.org/10.1073/pnas.1933744100 DO - 10.1073/pnas.1933744100 ID - Kleer2003 ER - TY - JOUR AU - Bracken, A. P. AU - Pasini, D. AU - Capra, M. PY - 2003 DA - 2003// TI - EZH2 is downstream of the pRB-E2F pathway, essential for proliferationand amplified in cancer JO - EMBO J VL - 22 UR - https://doi.org/10.1093/emboj/cdg542 DO - 10.1093/emboj/cdg542 ID - Bracken2003 ER - TY - JOUR AU - Deb, G. AU - Thakur, V. S. AU - Gupta, S. PY - 2013 DA - 2013// TI - Multifaceted role of EZH2 in breast and prostate tumorigenesis: epigenetics and beyond JO - Epigenetics VL - 8 UR - https://doi.org/10.4161/epi.24532 DO - 10.4161/epi.24532 ID - Deb2013 ER - TY - JOUR AU - Khaled, W. T. AU - Choon Lee, S. AU - Stingl, J. PY - 2015 DA - 2015// TI - BCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cells JO - Nat Commun VL - 6 UR - https://doi.org/10.1038/ncomms6987 DO - 10.1038/ncomms6987 ID - Khaled2015 ER - TY - JOUR AU - Ding, L. AU - Erdmann, C. AU - Chinnaiyan, A. M. PY - 2006 DA - 2006// TI - Identification of EZH2 as a molecular marker for a precancerous state in morphologically normal breast tissues JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-05-4300 DO - 10.1158/0008-5472.CAN-05-4300 ID - Ding2006 ER - TY - JOUR AU - Ding, L. AU - Kleer, C. G. PY - 2006 DA - 2006// TI - Enhancer of Zeste 2 as a marker of preneoplastic progression in the breast JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-2384 DO - 10.1158/0008-5472.CAN-06-2384 ID - Ding2006 ER - TY - JOUR AU - Gonzalez, M. E. AU - Li, X. AU - Toy, K. PY - 2009 DA - 2009// TI - Downregulation of EZH2 decreases growth of estrogen receptor-negative invasive breast carcinoma and requires BRCA1 JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2008.433 DO - 10.1038/onc.2008.433 ID - Gonzalez2009 ER -